AI Transparency Report
National Cancer Center Inc demonstrates consistent financial activity over the past decade, with revenues generally exceeding expenses, contributing to a steady growth in assets. For instance, in the 202303 period, revenue was $4,551,747 against expenses of $4,525,239, indicating a slight surplus. The organization's assets have grown significantly from $1,562,089 in 201403 to $3,829,399 in 202303, suggesting sound financial management and accumulation of resources.
However, a notable aspect of their financial reporting is the consistent declaration of 0% officer compensation across all available filings. While this could indicate a volunteer-led executive team, it warrants further investigation to understand how leadership is compensated, if at all, or if these roles are truly unpaid. This lack of reported executive compensation, while potentially positive, can also raise questions about the completeness of compensation disclosures if key leadership roles are indeed compensated through other means not captured under 'officer compensation'.
Without a detailed breakdown of expenses into program, administrative, and fundraising categories from the provided data, a precise assessment of spending efficiency is challenging. However, the consistent positive net income (revenue minus expenses) across most years suggests the organization is generally operating within its means and building reserves, which is a sign of financial stability.